grant

Delineating the mechanisms by which tumor immunity multicellular networks shape T cell state

Organization NORTHWESTERN UNIVERSITYLocation CHICAGO, UNITED STATESPosted 23 Aug 2023Deadline 31 Jul 2026
NIHUS FederalResearch GrantFY2025AcademiaAdvisory CommitteesAntigensAntitumor ResponseAreaAssayB blood cellsB cellB cellsB-Cell Attracting Chemokine 1B-CellsB-Lymphocyte ChemoattractantB-LymphocytesB-cellBCA1BLC geneBLC proteinBehaviorBioassayBiologicalBiological AssayBiologyBlood VesselsBody TissuesCD8 CellCD8 T cellsCD8 lymphocyteCD8+ T cellCD8+ T-LymphocyteCD8-Positive LymphocytesCD8-Positive T-LymphocytesCRG-2CXCL10CXCL10 geneCXCL11CXCL11 geneCXCL13CXCL13 geneCancer PatientCancer TreatmentCancersCell BodyCell CommunicationCell InteractionCell-to-Cell InteractionCellsChemokine, CXC Motif, Ligand 13Chemotactic CytokinesChronicColorectal CancerCommunicationDataData SetDevelopment PlansEnvironmentEnvironmental FactorEnvironmental Risk FactorFacultyFeedbackFilamentous FungiGeneral HospitalsGenesGrantH174HistoryHomologous Chemotactic CytokinesHumanHybridsHypoxiaHypoxicI-TACIFI10IFNIFN-GammaIFN-gIFN-γIFNGIFNγINP10IP-10IP-9IP9ImmuneImmune InterferonImmune mediated therapyImmunesImmunityImmunologically Directed TherapyImmunotherapyIn Situ HybridizationIntercrinesInterferon GammaInterferon Type IIInterferonsInvestigationLaboratoriesLeadershipLigandsLymph Node Reticuloendothelial SystemLymph node properLymphatic nodesMMR deficiencyMOB-1MalignantMalignant - descriptorMalignant CellMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMalignant Tumor of the LungMalignant neoplasm of lungMapsMassachusettsMentorsMentorshipMicroscopyMismatch RepairMismatch Repair DeficiencyModern ManMoldsMorphologyNeighborhoodsNon-Polyadenylated RNAOxygen DeficiencyPD-1 blockadePD1 blockadePathologistPathologyPathway interactionsPatientsPhenotypePhysiciansPopulationPositionPositioning AttributePost-Replication Mismatch RepairPostdocPostdoctoral FellowProcessProfessional CompetencePulmonary CancerPulmonary malignant NeoplasmRNARNA Gene ProductsRecording of previous eventsRecurrenceRecurrentResearchResearch AssociateResearch ProposalsResearch SpecimenRibonucleic AcidRoleSCYB10SCYB11SCYB13SCYB9BSIS cytokinesSamplingScientistSeriesShapesSmall Inducible Cytokine Subfamily B, Member 13SpecimenStem Cell likeStructureT cell responseT-Cell ActivationT-Cell ProliferationT-CellsT-LymphocyteT8 CellsT8 LymphocytesTask ForcesTechnical ExpertiseTherapeuticTissuesTrainingTumor ImmunityWritingactivate T cellsadvisory teamanti-PD-1 blockadeanti-PD1 blockadeanti-cancer therapyanti-tumor immune responseanti-tumor immunityanti-tumor responseantitumor immunityb-R1biologiccancer cellcancer immunitycancer immunologycancer therapycancer-directed therapycareer developmentcareer skillcell behaviorcell typecellular behaviorchemoattractant cytokinechemokineclinical significanceclinically significantcombatenvironmental riskexhaustexhaustionfightinggIP-10historieshuman DNAimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyimmunogenimprovedin situ Hybridization Geneticsin situ Hybridization Staining Methodin vitro testinginstructorlFN-Gammalung cancerlymph glandlymph nodeslymphnodesmalignancyneoplasm immunologyneoplasm/cancerpathwaypost-docpost-doctoralpost-doctoral traineeprogenitor capacityprogenitor cell likeprogenitor-likeprogramsrecruitresearch associatesresponsescRNA sequencingscRNA-seqsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingskillssocial rolestem cell characteristicsstem-likestemnesstechnical skillsthymus derived lymphocytetranscriptomicstranslational opportunitiestranslational potentialtumortumor immunologyvascular
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

T cells are greatly impacted by their environment, interacting with neighboring cells that may attract,
stimulate, inhibit, and otherwise alter T cell activity. Examining multicellular tissue organization is thus required

for unraveling the T cell anti-tumor response. Yet, little is known about what multicellular networks exist in

cancer, how they are organized, and how they modulate T cell activity. This project explores the mechanistic

basis of a tumor immunity multicellular network (hub) discovered in the candidate’s (Dr. Jonathan Chen) recent

single cell transcriptomic study of human colorectal cancer. The objective of this proposal is to investigate the

composition, spatial organization and function of this immunity hub in relation to the anti-tumor T cell response.

This proposal aims to (1) spatially map cellular interactions in the immunity hub that may shape T cell behavior

and (2) identify environmental factors in the immunity hub shaping CXCL13+ CD8 T cell state and uncover the

role of CXCL13 in CRC. The candidate anticipates these studies will demonstrate that the newly discovered

tumor immunity multicellular network recruits tumor-specific T cells, and that multiple cell types within the hub

participate in shaping the state of these T cells. Furthermore, this investigation of the immunity hub is likely to

identify promising strategies for therapeutic manipulation.

The candidate, Dr. Jonathan Chen, is currently a postdoc in the lab of Dr. Nir Hacohen and an

Instructor in the Department of Pathology of the Massachusetts General Hospital. The proposal incorporates

specific technical skills that will be required for the project, including training in analysis of ultra-highplex RNA

in situ hybridization datasets. The structured career development plan includes training and mentorship in

laboratory management, scientific leadership, research communication, grant writing, and other critical career

skills. These technical and career skills will be acquired under the guidance of Dr. Nir Hacohen, who will serve

as primary mentor and has a history of trainees obtaining faculty positions in academia, and Dr. Eli Van Allen

as computational co-mentor. A Research Advisory Committee of world-class scientists including Drs. Arlene

Sharpe, David Rimm, and David Ting will provide additional support and guidance. Through this

comprehensive program, the candidate will acquire a unique set of research skills that will enable him to

transition to an independent physician-scientist faculty position with a lab focused on basic mechanisms and

therapeutic opportunities in cancer immunology.

Grant Number: 5K08CA273547-03
NIH Institute/Center: NIH

Principal Investigator: Jonathan Chen

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →